John Celebi
2023
In 2023, John Celebi earned a total compensation of $1M as President and Chief Executive Officer at Sensei Biotherapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,743 |
|---|---|
| Option Awards | $99,554 |
| Salary | $532,167 |
| Stock Awards | $30,459 |
| Other | $64,366 |
| Total | $1,012,289 |
Celebi received $532.2K in salary, accounting for 53% of the total pay in 2023.
Celebi also received $285.7K in non-equity incentive plan, $99.6K in option awards, $30.5K in stock awards and $64.4K in other compensation.
Rankings
In 2023, John Celebi's compensation ranked 1,163rd out of 2,785 executives tracked by ExecPay. In other words, Celebi earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,163 out of 2,785 | 58th |
Division Manufacturing | 699 out of 1,525 | 54th |
Major group Chemicals And Allied Products | 470 out of 864 | 46th |
Industry group Drugs | 458 out of 827 | 45th |
Industry Pharmaceutical Preparations | 314 out of 592 | 47th |
Source: SEC filing on April 29, 2024.
Celebi's colleagues
We found two more compensation records of executives who worked with John Celebi at Sensei Biotherapeutics in 2023.